Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD Eli Lilly & CO Transaction History

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD

$385 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $1.87 Million - $2.18 Million	-5,830 Reduced 54.0%	4,967 $1.82 Million
Q4 2020 Jan 25, 2021	BUY	$130.46 - $172.63 $125,502 - $166,070	962 Added 9.78%	10,797 $1.82 Million
Q2 2020 Jul 28, 2020	BUY	$136.42 - $164.18 $1.34 Million - $1.61 Million	9,835 New	9,835 $1.62 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$76.4 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.1 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$51.9 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.5 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.7 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD, based on Form 13F filings with the SEC.

News

Stay updated on Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD with notifications on news.

Account